Amgen seeks FDA approval for monthly dosing option for Repatha
 

Amgen seeks FDA approval for monthly dosing option for Repatha
(Reuters) - Amgen Inc said it had asked the U.S. Food and Drug Administration to approve a monthly single-dosing option for its recently approved cholesterol drug, Repatha.
http://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1 http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...OE:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...OE:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/ojssxDH6a0w